Atlas Trials

Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis

Clinical trial NCT00192517 · COMPLETED

Trial details

NCT number
NCT00192517
Sponsor
MedImmune LLC
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Psoriasis
Start date
2003-12-01
Primary completion
2004-08-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.